Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional Results available

A Study of Guselkumab in Participants With Active Psoriatic Arthritis

ClinicalTrials.gov ID: NCT04882098

Public ClinicalTrials.gov record NCT04882098. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 1:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Subcutaneously Administered Guselkumab in Improving the Signs and Symptoms and Inhibiting Radiographic Progression in Participants With Active Psoriatic Arthritis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) by assessing the reduction in signs and symptoms of PsA.

Study identification

NCT ID
NCT04882098
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Enrollment
1,054 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 17, 2021 (Actual)
Primary completion
Dec 30, 2024 (Actual)
Completion
Oct 6, 2027 (Estimated)
Last update posted
Sep 25, 2026

2021 – 2027

United States locations

U.S. sites
23
U.S. states
14
U.S. cities
23
Facility City State ZIP Site status
Rheumatology Associates Birmingham Alabama 35205 —
Arizona Arthritis and Rheumatology Research PLLC Flagstaff Arizona 86001-6218 —
Arizona Arthritis & Rheumatology Associates PC Glendale Arizona 85306 —
Arizona Arthritis & Rheumatology Research, PLLC Tucson Arizona 85704 —
Advanced Medical Research La Palma California 90624 —
Rheumatology Center of San Diego San Diego California 92128 —
Medvin Clinical Research, Inc. Whittier California 90606 —
Heuer M.D. Research Orlando Florida 32819 —
The Arthritis Center, Inc. Palm Harbor Florida 34684 —
Forcare Clinical Research Inc Tampa Florida 33624 —
Klein And Associates M D P A Hagerstown Maryland 21740 —
Advanced Rheumatology Okemos Michigan 48864 —
Arthritis Consultants St Louis Missouri 63141 —
Glacier View Research Institute Kalispell Montana 59901-3158 —
NYU Langone Ambulatory Care Brooklyn Heights Brooklyn New York 11201 —
PMG Research of Salisbury Salisbury North Carolina 28144 —
STAT Research, Inc. Springboro Ohio 45342 —
Altoona Center For Clinical Research Duncansville Pennsylvania 16635 —
Dr. Ramesh Gupta Memphis Tennessee 38119 —
Austin Regional Clinic Austin Texas 78731 —
Adriana Pop Moody MD Clinic PA Corpus Christi Texas 78404 —
Southwest Rheumatology Research LLC Mesquite Texas 75150 —
Arthritis And Osteoporosis Clinic Waco Texas 76710 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 257 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04882098, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 25, 2026 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04882098 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →